Status:
COMPLETED
Peripherical Neuromuscular Electrical Stimulation in Systemic Autoimmune Myopathies
Lead Sponsor:
University of Sao Paulo
Conditions:
Electrical Remodeling
Rheumatic Diseases
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Systemic autoimmune myopathies are a heterogeneous group of rheumatic diseases with progressive skeletal muscle weakness. The relevance of the peripherical neuromuscular electrical stimulation has nev...
Detailed Description
Systemic autoimmune myopathies are a heterogeneous group of rheumatic diseases that primarily affect the skeletal muscles. Despite these advances, this group of diseases still continues to be associat...
Eligibility Criteria
Inclusion
- Classification criteria - EULAR/ACR 2017
- Classification criteria - Connors et al.
- Objective muscle limb weakness
Exclusion
- Neoplasia
- Using heart pacemarker
- Using visceral metalic clips
- Infections (HIV, HTLV-1, Hepatitis, etc)
- Pregnancy
- Previous historical of convulsions or epilepsies
Key Trial Info
Start Date :
November 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 29 2021
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT03751644
Start Date
November 1 2018
End Date
April 29 2021
Last Update
April 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samuel K Shinjo
São Paulo, Brazil, 01246903